1. Home
  2. OPAL vs CRVO Comparison

OPAL vs CRVO Comparison

Compare OPAL & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OPAL Fuels Inc.

OPAL

OPAL Fuels Inc.

HOLD

Current Price

$2.61

Market Cap

78.3M

Sector

Utilities

ML Signal

HOLD

Logo CervoMed Inc.

CRVO

CervoMed Inc.

HOLD

Current Price

$8.28

Market Cap

89.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPAL
CRVO
Founded
1998
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Natural Gas Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
78.3M
89.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OPAL
CRVO
Price
$2.61
$8.28
Analyst Decision
Sell
Strong Buy
Analyst Count
4
6
Target Price
$2.81
$21.50
AVG Volume (30 Days)
191.5K
82.5K
Earning Date
11-06-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$329,243,000.00
$6,159,786.00
Revenue This Year
$17.15
N/A
Revenue Next Year
$22.04
N/A
P/E Ratio
$112.28
N/A
Revenue Growth
7.26
N/A
52 Week Low
$1.26
$1.80
52 Week High
$4.08
$16.94

Technical Indicators

Market Signals
Indicator
OPAL
CRVO
Relative Strength Index (RSI) 58.14 48.34
Support Level $2.50 $8.13
Resistance Level $2.74 $9.22
Average True Range (ATR) 0.15 0.64
MACD 0.03 -0.12
Stochastic Oscillator 79.34 23.18

Price Performance

Historical Comparison
OPAL
CRVO

About OPAL OPAL Fuels Inc.

OPAL Fuels Inc is a fully integrated, nationwide leader in the production and distribution of low-carbon intensity renewable natural gas. The company is also engaged in the marketing and distribution of RNG to heavy-duty trucking and other hard-to-de-carbonize industrial sectors. The company designs, develops, constructs, operates, and services Fueling Stations for trucking fleets across the country that use natural gas to displace diesel as their transportation fuel. The company derives revenue from the sale of Renewable Power, design, development, construction, and service of Fueling Stations, and sales of RNG produced by OPAL and third parties as pipeline-quality natural gas.

About CRVO CervoMed Inc.

CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Share on Social Networks: